宏源药业 - Financials

宏源药业 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012
+Revenue	1.8B	2.1B	2.1B	1.6B	1.3B	1.6B	1.3B	1.3B	1.1B	1.0B	1.0B	947.0M	921.0M
Revenue Growth %	-13.8%	-0.4%	30.8%	21.1%	-18.7%	20.5%	4.0%	18.9%	7.2%	-2.7%	8.9%	2.8%	--
Total Revenue	1.8B	2.1B	2.1B	1.6B	1.3B	1.6B	1.3B	1.3B	1.1B	1.0B	1.0B	947.0M	921.0M
Cost Of Revenue	1.6B	1.8B	1.6B	1.0B	802.0M	1.0B	1.0B	1.0B	779.0M	769.0M	828.0M	800.0M	798.0M
+Gross Profit	216.0M	267.0M	482.0M	531.0M	501.0M	592.0M	297.0M	252.0M	296.0M	234.0M	203.0M	147.0M	123.0M
Gross Margin %	12.2%	13.0%	23.4%	33.7%	38.4%	37.0%	22.3%	19.7%	27.5%	23.3%	19.7%	15.5%	13.4%
Total Operating Cost	1.7B	2.0B	1.8B	1.2B	977.0M	1.3B	1.3B	1.3B	987.0M	933.0M	964.0M	920.0M	906.0M
Selling Expenses	37.3M	37.7M	36.5M	37.0M	33.5M	71.9M	69.6M	70.0M	59.8M	47.3M	49.7M	42.8M	45.1M
Admin Expenses	54.1M	60.8M	66.5M	71.4M	63.9M	60.3M	45.6M	65.8M	102.0M	74.5M	43.3M	36.5M	24.5M
Rd Expenses	59.2M	68.8M	64.0M	48.7M	44.5M	53.9M	40.5M	39.9M	--	--	--	--	--
Finance Expenses	-3.0M	-3.4M	-11.0M	4.2M	20.5M	30.3M	43.2M	35.4M	28.4M	33.4M	37.2M	37.3M	36.3M
+Operating Income	60.0M	106.0M	480.0M	548.0M	324.0M	417.0M	27.3M	37.4M	88.8M	73.3M	67.7M	22.9M	605,400
Operating Margin %	3.4%	5.2%	23.3%	34.7%	24.9%	26.0%	2.1%	2.9%	8.3%	7.3%	6.6%	2.4%	0.1%
Non Operating Income	128,900	156,200	309,900	56,000	521,300	70,700	1.4M	7.5M	3.3M	4.6M	11.8M	10.3M	9.1M
Non Operating Expenses	482,700	7.2M	2.3M	3.4M	19.1M	40.4M	4.5M	6.6M	13.7M	1.6M	103,900	808,900	1.3M
Investment Income	3.1M	19.4M	170.0M	190.0M	-14.7M	90.2M	-2.7M	-304,500	-35,100	2.7M	814,200	-4.7M	-14.0M
Fair Value Change Income	3.8M	2.9M	--	--	--	--	--	--	--	--	--	--	--
Asset Disposal Income	533,600	568,500	14.4M	-4,700	1.9M	-397,400	172,400	6.8M	--	--	--	--	--
Asset Impairment Loss	34.8M	26.4M	39.2M	11.5M	8.1M	43.8M	68.7M	9.6M	9.3M	4.9M	1.3M	600,300	612,200
Other Income	31.0M	24.1M	24.9M	13.2M	11.6M	9.5M	8.5M	7.6M	--	--	--	--	--
Income Before Tax	59.7M	98.6M	478.0M	545.0M	306.0M	377.0M	24.2M	38.3M	78.4M	76.3M	79.4M	32.4M	8.5M
Income Tax	8.2M	11.4M	43.2M	51.2M	48.4M	62.8M	12.3M	5.4M	13.5M	11.2M	11.7M	5.2M	3.3M
+Net Income	51.5M	87.2M	435.0M	494.0M	257.0M	314.0M	11.9M	32.9M	64.9M	65.1M	67.7M	27.2M	5.1M
Net Margin %	2.9%	4.2%	21.1%	31.3%	19.7%	19.6%	0.9%	2.6%	6.0%	6.5%	6.6%	2.9%	0.6%
Net Income Attributable	51.5M	87.2M	435.0M	494.0M	257.0M	314.0M	12.2M	32.9M	65.0M	64.9M	68.2M	28.2M	5.2M
Minority Interest	-3,300	--	--	--	--	--	-357,800	-2,500	-72,400	226,300	-590,400	-951,200	-46,000
Eps Basic	0.13	0.22	1.23	1.40	0.73	0.89	0.03	0.09	0.18	0.20	0.49	0.40	0.26
Eps Diluted	0.13	0.22	1.23	1.40	0.73	0.89	0.03	0.09	0.18	0.42	0.49	0.20	0.26

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012
Cash And Equivalents	746.0M	422.0M	395.0M	120.0M	264.0M	197.0M	160.0M	122.0M	53.4M	178.0M	178.0M	99.1M	85.8M
Trading Financial Assets	900.0M	1.5B	--	--	3.0M	--	--	--	--	--	--	--	--
Accounts Receivable	236.0M	211.0M	314.0M	135.0M	104.0M	93.8M	97.3M	--	106.0M	104.0M	99.4M	70.0M	47.1M
Notes Receivable	290.0M	171.0M	182.0M	170.0M	136.0M	194.0M	236.0M	--	69.9M	40.8M	71.7M	34.7M	21.8M
Notes And Accounts Receivable	527.0M	382.0M	496.0M	305.0M	240.0M	288.0M	333.0M	185.0M	176.0M	144.0M	171.0M	105.0M	68.9M
Prepayments	38.5M	34.4M	18.8M	12.3M	14.2M	13.6M	7.4M	8.3M	4.5M	15.0M	26.0M	18.6M	24.8M
Inventory	271.0M	192.0M	353.0M	384.0M	343.0M	288.0M	141.0M	141.0M	126.0M	143.0M	123.0M	135.0M	112.0M
Total Current Assets	3.0B	3.2B	1.7B	1.0B	941.0M	983.0M	669.0M	492.0M	389.0M	502.0M	534.0M	402.0M	311.0M
Long Term Equity Investment	204.0M	228.0M	335.0M	242.0M	97.2M	113.0M	8.5M	4.6M	4.9M	4.9M	2.5M	2.1M	8.2M
Fixed Assets	--	1.5B	666.0M	548.0M	516.0M	492.0M	570.0M	--	605.0M	409.0M	253.0M	266.0M	269.0M
Fixed Assets Total	1.7B	1.5B	666.0M	548.0M	516.0M	492.0M	570.0M	570.0M	605.0M	409.0M	254.0M	266.0M	270.0M
Construction In Progress	--	376.0M	946.0M	334.0M	67.6M	62.1M	333.0M	--	41.8M	94.0M	84.3M	58.3M	19.2M
Construction In Progress Total	631.0M	376.0M	946.0M	334.0M	67.6M	64.5M	333.0M	192.0M	41.8M	94.0M	84.3M	58.3M	19.2M
Intangible Assets	182.0M	183.0M	174.0M	194.0M	71.1M	75.0M	81.3M	95.8M	101.0M	108.0M	60.5M	35.2M	35.4M
Long Term Deferred Expenses	5.5M	5.9M	6.9M	12.0M	10.7M	8.1M	2.1M	12.1M	6.0M	6.2M	5.9M	6.0M	5.3M
Total Non Current Assets	2.8B	2.4B	2.2B	1.4B	811.0M	800.0M	1.1B	1.1B	861.0M	747.0M	427.0M	389.0M	339.0M
Total Assets	5.8B	5.7B	3.9B	2.4B	1.8B	1.8B	1.8B	1.6B	1.2B	1.2B	961.0M	791.0M	650.0M
Short Term Borrowings	59.3M	--	17.6M	20.1M	148.0M	113.0M	124.0M	250.0M	172.0M	181.0M	221.0M	281.0M	238.0M
Accounts Payable	433.0M	334.0M	457.0M	239.0M	134.0M	172.0M	179.0M	--	101.0M	107.0M	84.5M	85.6M	64.7M
Advance Receipts	--	--	--	--	--	27.0M	18.2M	22.0M	30.0M	31.2M	17.0M	25.4M	21.5M
Contract Liabilities	13.9M	19.8M	31.0M	29.7M	13.9M	--	--	--	--	--	--	--	--
Total Current Liabilities	1.1B	915.0M	1.3B	618.0M	502.0M	685.0M	936.0M	674.0M	475.0M	574.0M	620.0M	604.0M	485.0M
Long Term Borrowings	230.0M	276.0M	342.0M	47.2M	--	85.9M	138.0M	250.0M	128.0M	110.0M	50.0M	19.0M	25.0M
Total Non Current Liabilities	328.0M	376.0M	442.0M	137.0M	65.3M	170.0M	263.0M	339.0M	200.0M	161.0M	80.4M	19.0M	25.0M
Total Liabilities	1.5B	1.3B	1.8B	754.0M	567.0M	855.0M	1.2B	1.0B	675.0M	735.0M	700.0M	623.0M	510.0M
Paid In Capital	400.0M	400.0M	353.0M	353.0M	353.0M	353.0M	353.0M	353.0M	353.0M	168.0M	72.0M	70.0M	70.0M
Capital Reserve	2.2B	2.2B	22.1M	20.6M	20.6M	20.6M	20.6M	20.6M	20.6M	205.0M	120.0M	3.2M	2.7M
Surplus Reserve	191.0M	185.0M	176.0M	138.0M	88.5M	64.4M	30.0M	27.1M	22.2M	14.5M	7.1M	8.6M	5.6M
Retained Earnings	1.6B	1.6B	1.6B	1.2B	722.0M	489.0M	209.0M	200.0M	172.0M	119.0M	61.7M	77.2M	50.9M
Minority Equity	466,700	--	--	--	--	--	--	6.8M	6.8M	6.8M	--	9.0M	10.0M
Equity Attributable	4.4B	4.4B	2.1B	1.7B	1.2B	927.0M	613.0M	601.0M	568.0M	507.0M	261.0M	159.0M	129.0M
Total Equity	4.4B	4.4B	2.1B	1.7B	1.2B	927.0M	613.0M	607.0M	574.0M	514.0M	261.0M	168.0M	139.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012
Cash From Sales	1.1B	1.4B	1.3B	833.0M	885.0M	971.0M	819.0M	800.0M	755.0M	840.0M	735.0M	703.0M	1.1B
Tax Refunds Received	40.0M	31.8M	34.8M	3.9M	2.1M	627,600	22.5M	4.7M	1.2M	2.0M	77,400	452,200	679,700
Total Operating Cash Inflow	1.2B	1.4B	1.3B	847.0M	901.0M	976.0M	852.0M	815.0M	766.0M	862.0M	765.0M	745.0M	1.1B
Cash Paid For Goods	925.0M	1.0B	772.0M	309.0M	446.0M	460.0M	473.0M	468.0M	446.0M	555.0M	496.0M	574.0M	971.0M
Cash Paid To Employees	199.0M	195.0M	173.0M	143.0M	127.0M	137.0M	99.7M	109.0M	94.2M	67.3M	56.4M	41.0M	40.2M
Taxes Paid	20.8M	98.9M	80.6M	93.3M	89.4M	66.6M	48.6M	67.5M	55.0M	35.7M	43.8M	31.6M	15.8M
Total Operating Cash Outflow	1.2B	1.4B	1.1B	651.0M	758.0M	740.0M	680.0M	723.0M	653.0M	710.0M	645.0M	692.0M	1.0B
Operating Cash Flow	-15.8M	35.3M	215.0M	196.0M	142.0M	236.0M	172.0M	92.7M	113.0M	152.0M	119.0M	53.7M	47.6M
Total Investing Cash Inflow	4.2B	3.2B	227.0M	1.3M	254.0M	289.0M	5.4M	98.5M	1.8M	1.2M	513,300	4.2M	867,700
Total Investing Cash Outflow	3.8B	5.3B	597.0M	259.0M	155.0M	171.0M	55.4M	324.0M	178.0M	146.0M	57.8M	62.0M	92.4M
Investing Cash Flow	414.0M	-2.1B	-370.0M	-258.0M	99.5M	118.0M	-50.0M	-225.0M	-176.0M	-144.0M	-57.3M	-57.8M	-91.6M
Cash From Borrowings	51.1M	21.3M	494.0M	110.0M	200.0M	184.0M	203.0M	529.0M	387.0M	338.0M	381.0M	311.0M	256.0M
Dividends And Interest Paid	30.9M	53.8M	15.0M	2.2M	8.7M	29.2M	30.0M	20.0M	21.8M	22.1M	20.5M	37.2M	62.2M
Debt Repayments	65.6M	97.6M	54.9M	188.0M	290.0M	340.0M	371.0M	283.0M	401.0M	329.0M	420.0M	278.0M	152.0M
Total Financing Cash Inflow	51.6M	2.3B	494.0M	129.0M	210.0M	245.0M	563.0M	678.0M	505.0M	666.0M	669.0M	508.0M	306.0M
Total Financing Cash Outflow	229.0M	157.0M	204.0M	194.0M	364.0M	554.0M	647.0M	525.0M	538.0M	601.0M	692.0M	525.0M	253.0M
Financing Cash Flow	-177.0M	2.2B	290.0M	-65.8M	-155.0M	-309.0M	-83.9M	153.0M	-33.1M	65.6M	-23.3M	-17.4M	53.0M
Net Change In Cash	226.0M	120.0M	141.0M	-128.0M	79.8M	46.4M	40.1M	20.4M	-96.2M	72.9M	38.8M	-21.5M	9.0M
Ending Cash Balance	582.0M	356.0M	237.0M	95.8M	224.0M	144.0M	98.0M	57.9M	37.5M	134.0M	60.8M	22.0M	40.8M
Capex	160.0M	475.0M	507.0M	259.0M	56.9M	104.0M	55.4M	324.0M	175.0M	104.0M	57.8M	59.9M	92.4M